Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods. 

TCT 2024 | Utilización de balones cubiertos de fármacos para el tratamiento de la rama lateral en técnica de stent provisional

Based on the CHOICE-CLOSURE and MASH studies, double ProGlide use was associated with fewer access complications than the Manta device. Consequently, the former became the most accepted therapeutic option.

The ACCESS-TAVI study included patients with severe aortic stenosis scheduled for transfemoral TAVI, randomly assigned (1:1) to suture-and-plug closure (ProGlide and Angio-Seal) or suture-only closure (double ProGlide).

The primary objective was assessing a composite of major or minor vascular access-related complications (VARC-3 criteria) during hospitalization. Ultrasound-guided puncture was recommended, while secondary access was used at the operator’s discretion.

A total of 454 patients were included. Their average age was 80 years; 51.7% of subjects were women, and 11.3% had peripheral arterial disease. Among patients, 49.6% had no calcification, 21.9% had mild calcification, and 97% showed mild or no tortuosity. Ultrasound-assisted puncture was used in 57.8% of cases, and the right transfemoral access was the preferred choice (88.7%). A secondary transradial access was used in 40.9% of cases.

Read also: TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions.

In the analysis of the primary endpoint, vascular complications, the suture/plug group had 27% events vs 54% in the suture-only group, with a relative risk [RR] of 0.55 (95% confidence interval [CI]: 0.44-0.68; P ≤0.001). Reduced events were mainly due to fewer minor vascular complications and bleeding grade ≥ 2.

The authors concluded that the use of suture-and-plug closure reduces vascular complications compared with suture-only closure and is associated with shorter time to hemostasis.

Presented by Tobias A. Rheude in the Late-Breaking Trials Sessions, TCT 2024, October 27-29, Washington, USA.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...